This inventor holds 12 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Gencia Corporation, Rivus Pharmaceuticals, Inc.. Active years: 2011-2020.
Company Filing History:
Years Active: 2011-2020
Title: Shaharyar Khan: Innovator in Pharmaceutical Sciences
Introduction
Shaharyar Khan is a prominent inventor based in Charlottesville, VA, known for his significant contributions to pharmaceutical sciences. With a total of 12 patents to his name, he has made remarkable advancements in the field, particularly in developing novel compounds for medical applications.
Latest Patents
Among his latest patents is a novel phenyl derivative, 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole, or a pharmaceutically acceptable salt thereof. This compound is particularly useful for regulating mitochondrial activity, reducing adiposity, and treating diseases such as diabetes and its associated complications. Another notable invention relates to compositions and methods for treating conditions affecting the epidermis, including wrinkles, sun-damaged skin, and symptoms of aged skin.
Career Highlights
Shaharyar Khan has worked with several reputable companies, including Gencia Corporation and Rivus Pharmaceuticals, Inc. His work has significantly impacted the development of therapeutic solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Shaharyar has collaborated with notable professionals, including Arthur Glenn Romero and Mikael C Herlevsen. These collaborations have further enhanced his innovative contributions to the field.
Conclusion
Shaharyar Khan's work exemplifies the spirit of innovation in pharmaceutical sciences. His patents and collaborations reflect his commitment to advancing medical treatments and improving patient outcomes.